aDepartment of Immunology, University Medical Center Utrecht, The Netherlands.
AIDS. 2011 Sep 10;25(14):1691-700. doi: 10.1097/QAD.0b013e32834981b3.
HIV-1 is known to adapt to the human immune system, leading to accumulation of escape mutations during the course of infection within an individual. Cross-sectional studies have shown an inverse correlation between the prevalence of human leukocyte antigen (HLA) alleles in a population and the number of cytotoxic T lymphocyte (CTL) escape mutations in epitopes restricted by those HLA alleles. Recently, it was demonstrated that at a population level HIV-1 is adapting to the humoral immune response, which is reflected in an increase in resistance to neutralizing antibodies over time. Here we investigated whether adaptations to cellular immunity have also accumulated during the epidemic.
We compared the number of CTL epitopes in HIV-1 strains isolated from individuals who seroconverted at the beginning of the HIV-1 epidemic and from individuals who seroconverted in recent calendar time.
The number of CTL epitopes in HIV-1 variants restricted by the most common HLA alleles in the population did not change significantly during the epidemic. In contrast, we found a significant loss of CTL epitopes restricted by HLA-B alleles associated with a low relative hazard of HIV-1 disease progression during the epidemic. Such a loss was not observed for CTL epitopes restricted by HLA-A alleles.
Despite the large degree of HLA polymorphism, HIV-1 has accumulated adaptations to CTL responses within 20 years of the epidemic. The fact that such adaptations are driven by the HLA-B molecules that provide best protection against HIV-1 disease progression has important implications for our understanding of HIV evolution.
已知 HIV-1 会适应人体免疫系统,导致个体感染过程中积累逃逸突变。横断面研究表明,人群中人类白细胞抗原(HLA)等位基因的流行率与受这些 HLA 等位基因限制的细胞毒性 T 淋巴细胞(CTL)逃逸突变数量呈反比。最近,有人证明 HIV-1 在群体水平上适应体液免疫反应,这反映在随着时间的推移,对中和抗体的耐药性增加。在这里,我们研究了在流行期间是否也积累了对细胞免疫的适应。
我们比较了在 HIV-1 流行初期和最近日历时间发生血清转换的个体中分离的 HIV-1 株中 CTL 表位的数量。
在流行期间,人群中最常见的 HLA 等位基因限制的 HIV-1 变异体中的 CTL 表位数量没有显著变化。相比之下,我们发现与 HIV-1 疾病进展的相对风险较低相关的 HLA-B 等位基因限制的 CTL 表位数量显著丢失。而 HLA-A 等位基因限制的 CTL 表位则没有观察到这种丢失。
尽管存在高度的 HLA 多态性,但在 HIV-1 流行的 20 年内,HIV-1 已经积累了对 CTL 反应的适应。这种适应是由提供最佳 HIV-1 疾病进展保护的 HLA-B 分子驱动的,这对我们理解 HIV 进化具有重要意义。